Schonfeld Strategic Advisors LLC Catalyst Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $198,928 - $291,976	16,887 New	16,887 $283,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $1.25 Million - $2.74 Million	176,506 New	176,506 $2.27 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $145,084 - $199,578	-23,288 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.31 - $8.31 $123,659 - $193,523	23,288 New	23,288 $193,000
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $93,202 - $156,377	-38,997 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $97,882 - $171,586	38,997	38,997 $153,000

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.